“Prescription of Glucagon-Like Peptide 1 (GLP-1) in the Treatment of Patients With Type 2 Diabetes and Obesity: A Literature Review”. Revista Eletrônica Acervo Médico, vol. 11, June 2022, p. e10289, https://doi.org/10.25248/reamed.e10289.2022.